Simulations Plus/SLP

$46.52

-2.77%
-
1D1W1MYTD1YMAX

About Simulations Plus

Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. The Company's segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer. Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. The Company provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. Its software and consulting services are provided to various industries, including biotechnology and cosmetics.

Ticker

SLP

Sector

Healthcare

Trading on

NASDAQ

Industry

Software & Programming

CEO

Shawn O'Connor

Employees

192

Headquarters

Lancaster, United States

Simulations Plus Metrics

BasicAdvanced
$956.28M
Market cap
92.48
P/E ratio
$0.52
EPS
0.69
Beta
$0.24
Dividend rate
0.5%
Dividend yield
$956.28M
0.69296
$52.69
$32.69
104.76K
$0.24
8.808
45.55%
166.885
5.73%
6.16%
6.07%
92.48
14.788
5.401
7.663
120.045
0.49%
0.5%
0.5%
18.86%
2.24%
12.73%
-1.12%

What the Analysts think about Simulations Plus

Analyst Ratings

Majority rating from 3 analysts.
Buy

Price Targets

Average projection from 3 analysts.
15.37% upside
High $55.00
Low $51.00
$46.52
Current price
$53.67
Average price target

Simulations Plus Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
21.85% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$18.3M
26.21%
Net income
$4M
110.53%
Profit margin
21.85%
66.79%

Simulations Plus Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 5.26%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.20
$0.02
$0.10
$0.20
-
Expected
$0.20
$0.18
$0.10
$0.19
$0.19
Surprise
-1.64%
-89.09%
0%
5.26%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Simulations Plus stock?

Simulations Plus (SLP) has a market cap of $956.28M as of April 13, 2024.

What is the P/E ratio for Simulations Plus stock?

The price to earnings (P/E) ratio for Simulations Plus (SLP) stock is 92.48 as of April 13, 2024.

Does Simulations Plus stock pay dividends?

Yes, the Simulations Plus (SLP) stock pays dividends to shareholders. As of April 13, 2024, the dividend rate is $0.24 and the yield is 0.5%. Simulations Plus has a payout ratio of 45.55% on a trailing twelve-month basis.

When is the next Simulations Plus dividend payment date?

The next Simulations Plus (SLP) dividend payment is scheduled for May 06, 2024.

What is the beta indicator for Simulations Plus?

Simulations Plus (SLP) has a beta rating of 0.69. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Simulations Plus stock price target?

The target price for Simulations Plus (SLP) stock is $53.67, which is 15.37% above the current price of $46.52. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Simulations Plus stock

Buy or sell Simulations Plus stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing